For Immediate Release
Brave New Films Runs Full Page Ad in New York Times Featuring 2,768 Doctors Calling for Release of McCain's Medical Records
LOS ANGELES - Brave New Films ran a full page ad in today's New York Times that
features an open letter from 2,768 doctors calling on Senator John
McCain to issue a full, public release of his medical records. The ad
is on page A7 of today's paper.
See the ad here: http://gobnf.org/i/trm/nyt_ad.
The ad features the names of thousands of doctors and statements from
Rachael A. Clark, M.D., Ph.D., Assistant Professor of Dermatology at
Harvard Medical School, Ronald Bronow, M.D., former Chief of
Dermatology at Cedars Sinai Medical Center in Los Angeles, Richard
Sagebiel, M.D., former Director of The Melanoma Center at UCSF, and
Robert Buxbaum, M.D., Associate Professor at Harvard Medical School.
"I feel it is critical that people understand how quickly and fatally
melanoma can recur, sometimes with decades of remission preceding a
rapid decline," Dr. Clark states in the advertisement. Dr. Sagebiel is
quoted arguing that McCain's restricted disclosure in May was "not
enough to render a serious judgment on this incredibly important
Earlier this week, CNN Medical Correspondent Dr. Sanjay Gupta discussed
the May disclosure, telling The Huffington Post: "We were given three
hours to go over 1,200 pages of records. That is a lot to go through.
It was very sort of cloak and dagger and I'm sure they had their
reasons. Given that I had my medical training, I was able to hone in on
what it thought was important more quickly. But the pages weren't
numbered, so I had no way of knowing what was missing... As a reporter
I can only comment on what I saw but I can't say by any means that this
was complete... As far as the secretiveness of it, what they said to us
is that you can't take anything out of the room, but you could make
notes. So it was a lot to go through in a short period of time."
John McCain has had four incidents of melanoma, the deadliest form of
skin cancer. In 2000, The Mayo Clinic in Scottsdale described the
melanoma resected from McCain's left temple as a Stage IIA cancer.
However, the Armed Services Institute of Pathology reviewed the same
slides and observed that there appeared to be two lesions, suggesting
the occurrence of a satellite metastasis and a Stage IIIB cancer. The
10-year survival rate for a Stage IIA melanoma is 64 percent. For a
Stage IIIB melanoma, the rate drops to 38 percent.